Other Current Assets - Ryvu Therapeutics SA (WSE:RVU) - Alpha Spread
R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 54.1 PLN -1.64% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

Ryvu Therapeutics SA
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ryvu Therapeutics SA
Other Current Assets Peer Comparison

Comparables:
I
IGN
M
MDB
S
SLV

Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
R
Ryvu Therapeutics SA
WSE:RVU
Other Current Assets
zł10.9m
CAGR 3-Years
122%
CAGR 5-Years
27%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Other Current Assets
zł0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Medicofarma Biotech SA
WSE:MDB
Other Current Assets
zł1m
CAGR 3-Years
195%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Selvita SA
WSE:SLV
Other Current Assets
zł8.8m
CAGR 3-Years
37%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ryvu Therapeutics SA's Other Current Assets?
Other Current Assets
10.9m PLN

Based on the financial report for Mar 31, 2024, Ryvu Therapeutics SA's Other Current Assets amounts to 10.9m PLN.

What is Ryvu Therapeutics SA's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
27%

Over the last year, the Other Current Assets growth was 207%. The average annual Other Current Assets growth rates for Ryvu Therapeutics SA have been 122% over the past three years , 27% over the past five years .

Back to Top